158 related articles for article (PubMed ID: 36069438)
1. Murine Broadly Reactive Antineuraminidase Monoclonal Antibodies Protect Mice from Recent Influenza B Virus Isolates and Partially Inhibit Virus Transmission in the Guinea Pig Model.
Tan J; Chromikova V; O'Dell G; Sordillo EM; Simon V; van Bakel H; Krammer F; McMahon M
mSphere; 2022 Oct; 7(5):e0092721. PubMed ID: 36069438
[TBL] [Abstract][Full Text] [Related]
2. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
Tan J; O'Dell G; Hernandez MM; Sordillo EM; Kahn Z; Kriti D; van Bakel H; Ellebedy AH; Wilson PC; Simon V; Krammer F; McMahon M
J Virol; 2022 Jan; 96(2):e0142121. PubMed ID: 34669506
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs.
McMahon M; Kirkpatrick E; Stadlbauer D; Strohmeier S; Bouvier NM; Krammer F
mBio; 2019 May; 10(3):. PubMed ID: 31113896
[TBL] [Abstract][Full Text] [Related]
4. Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.
Wohlbold TJ; Podolsky KA; Chromikova V; Kirkpatrick E; Falconieri V; Meade P; Amanat F; Tan J; tenOever BR; Tan GS; Subramaniam S; Palese P; Krammer F
Nat Microbiol; 2017 Oct; 2(10):1415-1424. PubMed ID: 28827718
[TBL] [Abstract][Full Text] [Related]
5. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
[TBL] [Abstract][Full Text] [Related]
6. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
7. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
[TBL] [Abstract][Full Text] [Related]
8. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
Kawai A; Yamamoto Y; Nogimori T; Takeshita K; Yamamoto T; Yoshioka Y
J Virol; 2021 Sep; 95(20):e0118021. PubMed ID: 34379511
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
[TBL] [Abstract][Full Text] [Related]
12. Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Rijal P; Wang BB; Tan TK; Schimanski L; Janesch P; Dong T; McCauley JW; Daniels RS; Townsend AR; Huang KA
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748388
[TBL] [Abstract][Full Text] [Related]
13. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses.
Wan H; Gao J; Xu K; Chen H; Couzens LK; Rivers KH; Easterbrook JD; Yang K; Zhong L; Rajabi M; Ye J; Sultana I; Wan XF; Liu X; Perez DR; Taubenberger JK; Eichelberger MC
J Virol; 2013 Aug; 87(16):9290-300. PubMed ID: 23785204
[TBL] [Abstract][Full Text] [Related]
15. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.
Piepenbrink M; Oladunni F; Nogales A; Khalil AM; Fitzgerald T; Basu M; Fucile C; Topham DJ; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
Microbiol Spectr; 2023 Aug; 11(4):e0472822. PubMed ID: 37318331
[TBL] [Abstract][Full Text] [Related]
16. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
17. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective.
Madsen A; Dai YN; McMahon M; Schmitz AJ; Turner JS; Tan J; Lei T; Alsoussi WB; Strohmeier S; Amor M; Mohammed BM; Mudd PA; Simon V; Cox RJ; Fremont DH; Krammer F; Ellebedy AH
Immunity; 2020 Oct; 53(4):852-863.e7. PubMed ID: 32976769
[TBL] [Abstract][Full Text] [Related]
18. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
19. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
[TBL] [Abstract][Full Text] [Related]
20. Highly conserved protective epitopes on influenza B viruses.
Dreyfus C; Laursen NS; Kwaks T; Zuijdgeest D; Khayat R; Ekiert DC; Lee JH; Metlagel Z; Bujny MV; Jongeneelen M; van der Vlugt R; Lamrani M; Korse HJ; Geelen E; Sahin Ö; Sieuwerts M; Brakenhoff JP; Vogels R; Li OT; Poon LL; Peiris M; Koudstaal W; Ward AB; Wilson IA; Goudsmit J; Friesen RH
Science; 2012 Sep; 337(6100):1343-8. PubMed ID: 22878502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]